MEDI2338

· MedImmune LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI2338, covering 2013-10-23 to 2013-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease [Phase 1]